Tag:
social media
Latest Headlines
Latest Headlines
Med device companies split on social media use
About half of medical device companies have tapped social networking websites for communications, yet a lesser number of devicemakers have refined their approaches to using sites such as LinkedIn, Facebook and Twitter.
Boehringer, pharmas turn to social gaming for online outreach
Boehringer Ingelheim wants to create a social game dubbed "Syrum" that would let players tend to virtual R&D projects and traffic in scientific talent and compounds, according to InPharm .
Pharma groups stand out in social media realm
According to a Pharmalot report, Astellas Pharma of Japan made a 1,100% jump in social media buzz from last week to the previous week.
Astellas, Lilly grab social-media limelight
Social media buzz can be both good and bad, and smart companies want to keep track of both.
Roche helps corral diabetes chitchat from Twitter
The Swiss drug giant is zeroing in on the diabetes community with the recent launch of a page on the social networking site called Diabetes Nest.
Tech startup cuts through social media noise for drug and device outfits
LiquidGrids's tech crawls the vast social media universe and picks up health-related conversations; the company hopes to find clients that will pay to hear what's being said.
Big Pharma and devicemakers plot careful social media moves
Major drug and device companies are abuzz about the possibilities and pratfalls of using social media, and some of the top layers in those industries weighed in during a conference discussion in Orlando this week.
CRO lobby steps up social media outreach on YouTube
Clinical research organizations have grown their share of global clinical research business over the years, and the contract drug developers have found an online platform to carry their message around the world: YouTube.
GSK to eavesdrop on social-media chatter with IT deal
GlaxoSmithKline ( $GSK ) wants to know what consumers are saying about it online so that it can do a better job with its digital marketing. So, the London-based drug giant has inked a multimillion-dollar deal with Infosys ( $INFY ) and Fabric Worldwide to gain insights into peoples' views about GSK products on social media and other websites.
GSK strikes deal to listen in on social media chatter
GlaxoSmithKline ( $GSK ) wants to know what consumers are saying about the drugmaker online.
